Differences

This shows you the differences between two versions of the page.

--- amanda_cohn [2022/04/21 23:15]
liam [Forum on Microbial Threats]
+++ amanda_cohn [2024/12/18 19:23] (current)
liam [COVID-19]
@@ Line 12: / Line 12: @@
 ===== Career and Affiliations =====
-==== Centres for Disease Control and Prevention ====
+==== Centers for Disease Control and Prevention ====
 Cohn is the Director of the Division of Birth Defects and Infant Disorders under the [[Center for Disease Control and Prevention|US Centers for Disease Control and Prevention]] (CDC).((CDC. (2021, December 17). //Amanda Cohn | Biographies | About Us | NCBDDD | CDC.// Centers for Disease Control and Prevention. https://archive.ph/bixnF)) In this role, she acts as a liaison representative on the [[National Advisory Committee on Immunization]] (NACI), responsible for approving [[COVID-19 vaccines]] in Canada.((//National Advisory Committee on Immunization (NACI): Membership and representation.// (2020, December 18). Wayback Machine; Government of Canada. https://web.archive.org/web/20201218222110/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html))
@@ Line 38: / Line 38: @@
 Cohn was a co-author on the study identifying the first [[SARS-CoV-2]] infection in the United States, published in March 2020 in the [[New England Journal of Medicine]].((Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., Diaz, G., Cohn, A., Fox, L., Patel, A., Gerber, S. I., Kim, L., Tong, S., Lu, X., Lindstrom, S., & Pallansch, M. A. (2020). //First Case of 2019 Novel Coronavirus in the United States.// New England Journal of Medicine, 382(10), 929–936. https://doi.org/10.1056/nejmoa2001191))
+===== External links =====
+  * [[https://wiki.whiteroseintelligence.com/en/Amanda-Cohn|White Rose Wiki]]